5KQ-56695-92473
1 vaccination
2 coded responses
4 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 281 / NC
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-17
Registered in v-safe
-
2021-04-17
Dose 1 — Pfizer-BioNTech
- 2021-04-17
-
2021-04-19
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Slight chest pain near diaphragmMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-04-20
Survey response — days 1–6 daily, dose 1MedDRA: Nasopharyngitis — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-04-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitAdult check-in
-
2021-04-21
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-23
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-17 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-19 | priority 2/3 | |
| 2021-04-20 | priority 2/3 | |
| 2021-04-21 | Successful 2021-04-23 |
Participant prefers to complete VAERS report online |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Slight chest pain near diaphragm
Systemic reaction (other): Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release